approval
saveENTYVIO (VEDOLIZUMAB) — FDA approval
March 14, 2024updated 5mo ago
community read0 votes
Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalENTYVIO (VEDOLIZUMAB) — FDA approvalMar 14, 2024
- approvalICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approvalMar 19, 2024
- approvalLIVTENCITY (MARIBAVIR) — FDA approvalMar 22, 2024
- approvalENTYVIO (VEDOLIZUMAB) — FDA approvalFeb 23, 2024
- approvalENTYVIO (VEDOLIZUMAB) — FDA approvalFeb 23, 2024
- approvalENTYVIO (VEDOLIZUMAB) — FDA approvalApr 18, 2024
comments(0)
5-min edit window · permanent after that